Merck and Ridgeback to Present Phase 3 Data for Molnupiravir, an Investigational Oral COVID-19 Antiviral Medicine, at American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meeting
KENILWORTH, N.J. & MIAMI–(BUSINESS WIRE)–$MRK #MERCK–Merck (NYSE: MRK), known as MSD outside the United States…
Saudi Arabia Hit 85% Digital: The Rails Under the Card Are Next
Creative Pass Studio Launches Unlimited Design Monthly Pass, Giving Agencies and Growing Businesses a Senior Creative Team Without Adding Headcount
Stardust Appoints Eamonn McHugh as CEO in Strategic Leadership Transition
SpeedyIndex Study Finds Only 3.7% of 15,389 Bought Backlinks Are in Google’s Index a Year Later
Canary Capital Launches the First U.S. Spot Staked INJ ETF (Ticker: INJC)